Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On FMC Corp (FMC)

Page 1 of 2

Hedge funds are not perfect. They have their bad picks just like everyone else. Micron, a stock hedge funds have loved, lost 50% during the last 12 months ending in October 30. Although hedge funds are not perfect, their consensus picks do deliver solid returns, however. Our data show the top 30 S&P 500 stocks among hedge funds at the end of September 2014 yielded an average return of 9.5% in the same time period, vs. a gain of 5.2% for the S&P 500 Index. Because hedge funds have a lot of resources and their consensus picks do well, we pay attention to what they think. In this article, we analyze what the elite funds think of FMC Corp (NYSE:FMC).

Is FMC Corp (NYSE:FMC) a sound investment right now? The best stock pickers are in a bullish mood. The number of bullish hedge fund bets rose by 12 in recent months. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article, we will examine companies such as Avis Budget Group Inc. (NASDAQ:CAR), Northstar Realty Finance Corp. (NYSE:NRF), and Patterson Companies, Inc. (NASDAQ:PDCO) to gather more data points.

Follow Fmc Corp
Trade (FMC) Now!

To most shareholders, hedge funds are viewed as unimportant, old investment tools of yesteryear. While there are greater than 8000 funds with their doors open today, We choose to focus on the crème de la crème of this club, about 700 funds. Most estimates calculate that this group of people administers the majority of the hedge fund industry’s total asset base, and by keeping an eye on their best picks, Insider Monkey has identified a number of investment strategies that have historically outperformed the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy outperformed the S&P 500 index by 12 percentage points a year for a decade in their back tests.

With all of this in mind, let’s check out the key action surrounding FMC Corp (NYSE:FMC).

Hedge fund activity in FMC Corp (NYSE:FMC)

At the end of the third quarter, a total of 33 of the hedge funds tracked by Insider Monkey held long positions in this stock, an increase of 57% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were boosting their stakes considerably (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Larry Robbins’s Glenview Capital has the biggest position in FMC Corp (NYSE:FMC), worth close to $226.3 million, corresponding to 1.1% of its total 13F portfolio. The second most bullish fund manager is Atlantic Investment Management, managed by Alexander Roepers, which holds a $181 million position; 17.2% of its 13F portfolio is allocated to the company. Other professional money managers that hold long positions include Robert Joseph Caruso’s Select Equity Group, Jeffrey Bronchick’s Cove Street Capital, and Michael Price’s MFP Investors.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!